Table 1 GRK substrates related to the regulation of blood pressure
GRK isoform | Substrate protein | Tissue/cells | Regulation of Substrate |
|---|---|---|---|
GPCR substrates | |||
GRK2 | ETAR | Rat mesenteric arterial smooth muscle cells [35]; rat aortic smooth muscle cells [37] | Inactive dominant-negative GRK2 or siRNA-Grk2 attenuates ETAR desensitization and its mediated VSMC contractile or migration signaling [35, 37] |
P2Y2R | Rat mesenteric artery [36]; rat mesenteric arterial smooth muscle cells [36]; rat aortic smooth muscle cells [37] | GRK2 inhibition or siRNA-Grk2 attenuates P2Y2R desensitization and its mediated VSMC contractile or migration signaling [36, 37] | |
β-AR | Mouse aortic arterial smooth muscle cells [34]; brachial artery [66]; HEK293 cells [76] | VSM-targeted overexpression of Grk2 attenuates β-AR signaling and vasodilation [34]; inhibition of GRK2 activity prevents β-AR desensitization [66]; GRK2 directly interacts with β2-AR and regulates its desensitization [76]; Grk2 knockout or GRK2 inhibition increases β-AR-mediated vasodilation [39] | |
AT1R | GRK2 inhibition reduces agonist-induced AT1R phosphorylation and prevents receptor desensitization [38]; Grk2 knockdown enhances renal AT1R-mediated ROS production [43]; cardiac-specific Grk2 expression attenuates Ang II-induced increase in cardiac contractility [32] | ||
D1R | Rat RPT cells [47, 49]; OK cells [48]; HEK293 cells [41, 75] and rat striatum [75] | GRK2 mediates H2O2 or insulin-caused renal D1R phosphorylation and impairs D1R-mediated inhibition of Na+-K+-ATPase activity [47, 48]; GRK2 increases D1R desensitization and phosphorylation [75]; Grk2 overexpression increases agonist-induced D1R phosphorylation [41] | |
α1D-AR | VSM | Grk2 knockout or peptide inhibition enhances α1D-AR-induced vasoconstriction [39] | |
GRK3 | α1-AR | Cardiac myocytes | GRK3 inhibition causes α1-AR hyper-responsiveness [73] |
D1R | HEK293 cells; rat striatum | GRK3 increases D1R desensitization and phosphorylation [75]; Grk3 overexpression increases dopamine-induced D1R phosphorylation [41] | |
β2-AR | HEK293 cells | GRK3 directly interacts with β2-AR and regulates its desensitization [76] | |
AT1R | HEK293 cells | Grk3 overexpression increases angiotensin II-induced AT1R phosphorylation [38] | |
GRK4 | D1R | CHO cells [15]; HEK293T cells [85]; Human RPT cells[15, 86]; Kidney [81]; Rat renal cortex [79]; | GRK4 phosphorylates the D1R, causing its constitutive desensitization and internalization [85]; GRK4 As-Odns decrease serine-phosphorylated D1R [79]; UTMD-mediated renal Grk4 siRNA delivery reduces D1R phosphorylation and blood pressure and increases D1R-mediated natriuresis and diuresis [81]; GRK4γ variants increase D1R phosphorylation and impair D1R-mediated cAMP production [15]; GRK4 inhibition blunts D1R desensitization [86] |
D3R | Human RPT cells | GRK4γ and GRK4α increase the phosphorylation of agonist-activated D3R [91] | |
AT1R | Thoracic aortic VSM cells [77]; HEK293 cells and human RPT cells [78]; kidney [78] | ||
ETBR | Renal cortex; rat RPT cells | hGRK4γ 142V increases but GRK4 depletion decreases renal ETBR phosphorylation [82] | |
AT2R | Renal cortex; rat RPT cells | hGRK4γ 142V increases renal AT2R phosphorylation and causes its dysfunction [93] | |
CCKBR | Renal cortex; rat RPT cells | hGRK4γ 142V increases but GRK4 silencing decreases renal CCKBR phosphorylation [170] | |
GRK5 | AT1R | HEK293 cells | Grk5 overexpression increases the angiotensin II-induced AT1R phosphorylation [38] |
β-AR | VSM-Grk5 over-expression increases blood pressure to a greater extent in male than female mice; β-AR stimulation induced vasoconstriction in male mice but decreased β-AR-induced vasodilation and increased angiotensin II sensitivity in female mice [122]; Cardiac-specific Grk5 expression increases β-AR desensitization but does not affect the contractile response to angiotensin II [32] | ||
D1R | HEK293 cells | Grk5 overexpression increases agonist-induced D1R phosphorylation [41] | |
GRK6 | D1R | Intestinal epithelial cells | GRK6 antibodies prevents the desensitization-mediated loss of D1R inhibition of Cl/HCO3- exchanger activity [130] |
Non-GPCR receptor substrates | |||
GRK4 | adipoR1 | Renal cortex; rat RPT cells | hGRK4γ 142V causes adipoR1 phosphorylation and desensitization [21] |
Non-receptor substrates | |||
GRK2 | ENaC | Salivary duct cells | GRK2 phosphorylates S633 in the C terminus of ENaC [44] |
Nedd4 and Nedd4-2 | HEK293T cells | GRK2 phosphorylates Nedd4 and Nedd4-2 [46] | |
GRK4 | HDAC4 | Mouse cardiomyocytes | GRK4 increases HDAC4 phosphorylation and decreases its binding to the beclin-1 promoter [28] |
NF-κB | Embryonic rat thoracic aortic smooth muscle cells | GRK4γ 142V increases NF-κB activity with more NF-κB bound to the AT1R promoter [77] | |
STAT1 | HK-2 cells and mouse kidney | GRK4 phosphorylates STAT1 [27] | |
HDAC1 | Human RPT cells and mouse kidney | GRK4γ 142V phosphorylates HDAC1 and promotes its nuclear export to the cytoplasm [78] | |